PlainPill

BPC-157 vs MK-677 for recovery

Short answer: For recovery, users rate them about the same: 96% report improvement with BPC-157 (494 reports) and 99% with MK-677 (106 reports).

BPC-157 has 0 meta-analyses and 0 randomized trials on PubMed; MK-677 has 0 and 15.

Based on 1,613 reports about BPC-157 and 978 about MK-677. Not medical advice.

BPC-157
Peptide
MK-677
Substance
Users say it helped54%helped919 reports · high confidence39%helped479 reports · high confidence
Verdict
Mixed
Mixed
ResearchDResearch: NoneBResearch: Moderate
Meta-analyses / RCTs0 / 00 / 15
Mainly used for
Recovery
% reporting improvement
96% (494)99% (106)
Pain & inflammation
% reporting improvement
86% (485)68% (22)
Sleep
% reporting improvement
80% (76)79% (170)
Appetite
% reporting improvement
64% (11)66% (228)
Mood
% reporting improvement
65% (128)52% (21)
Common side effectsfatigue, anhedonia, anxiety, headachewater retention, fatigue, stomach issues, hunger
Typical dose reportedNot listed12.5 mg / before dinner
BPC-157
What a user said
“after 2+ years of nothing working, this is the 1st thing to reverse significant muscle damage ... 40% increase in my range of motion, and nearly the same in muscle strength.”
Full BPC-157 profile →
MK-677
What a user said
“From my own experience (also have suffered from poor sleep), i experienced a noticeable increase in sleep quality even with a low dose.”
Full MK-677 profile →

Related comparisons

Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate